Cystatin C and the risk of death and cardiovascular events among elderly persons
- PMID: 15901858
- DOI: 10.1056/NEJMoa043161
Cystatin C and the risk of death and cardiovascular events among elderly persons
Abstract
Background: Cystatin C is a serum measure of renal function that appears to be independent of age, sex, and lean muscle mass. We compared creatinine and cystatin C levels as predictors of mortality from cardiovascular causes and from all causes in the Cardiovascular Health Study, a cohort study of elderly persons living in the community.
Methods: Creatinine and cystatin C were measured in serum samples collected from 4637 participants at the study visit in 1992 or 1993; follow-up continued until June 30, 2001. For each measure, the study population was divided into quintiles, with the fifth quintile subdivided into thirds (designated 5a, 5b, and 5c).
Results: Higher cystatin C levels were directly associated, in a dose-response manner, with a higher risk of death from all causes. As compared with the first quintile, the hazard ratios (and 95 percent confidence intervals) for death were as follows: second quintile, 1.08 (0.86 to 1.35); third quintile, 1.23 (1.00 to 1.53); fourth quintile, 1.34 (1.09 to 1.66); quintile 5a, 1.77 (1.34 to 2.26); 5b, 2.18 (1.72 to 2.78); and 5c, 2.58 (2.03 to 3.27). In contrast, the association of creatinine categories with mortality from all causes appeared to be J-shaped. As compared with the two lowest quintiles combined (cystatin C level, < or =0.99 mg per liter), the highest quintile of cystatin C (> or =1.29 mg per liter) was associated with a significantly elevated risk of death from cardiovascular causes (hazard ratio, 2.27 [1.73 to 2.97]), myocardial infarction (hazard ratio, 1.48 [1.08 to 2.02]), and stroke (hazard ratio, 1.47 [ 1.09 to 1.96]) after multivariate adjustment. The fifth quintile of creatinine, as compared with the first quintile, was not independently associated with any of these three outcomes.
Conclusions: Cystatin C, a serum measure of renal function, is a stronger predictor of the risk of death and cardiovascular events in elderly persons than is creatinine.
Copyright 2005 Massachusetts Medical Society.
Comment in
-
Chronic kidney disease in the elderly--how to assess risk.N Engl J Med. 2005 May 19;352(20):2122-4. doi: 10.1056/NEJMe058035. N Engl J Med. 2005. PMID: 15901867 No abstract available.
-
Cystatin C and the risk of death.N Engl J Med. 2005 Aug 25;353(8):842-4; author reply 842-4. doi: 10.1056/NEJMc051667. N Engl J Med. 2005. PMID: 16120867 No abstract available.
-
Cystatin C and the risk of death.N Engl J Med. 2005 Aug 25;353(8):842-4; author reply 842-4. N Engl J Med. 2005. PMID: 16124125 No abstract available.
-
Cystatin C and the risk of death.N Engl J Med. 2005 Aug 25;353(8):842-4; author reply 842-4. N Engl J Med. 2005. PMID: 16124126 No abstract available.
-
Is cystatin C more effective than creatinine in predicting adverse cardiovascular outcomes in elderly people?Nat Clin Pract Nephrol. 2005 Nov;1(1):8-9. doi: 10.1038/ncpneph0026. Nat Clin Pract Nephrol. 2005. PMID: 16932354 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous